Robert C. Smallridge

51.7k total citations · 3 hit papers
209 papers, 9.1k citations indexed

About

Robert C. Smallridge is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Robert C. Smallridge has authored 209 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Endocrinology, Diabetes and Metabolism, 54 papers in Molecular Biology and 32 papers in Genetics. Recurrent topics in Robert C. Smallridge's work include Thyroid Disorders and Treatments (63 papers), Thyroid Cancer Diagnosis and Treatment (63 papers) and Growth Hormone and Insulin-like Growth Factors (33 papers). Robert C. Smallridge is often cited by papers focused on Thyroid Disorders and Treatments (63 papers), Thyroid Cancer Diagnosis and Treatment (63 papers) and Growth Hormone and Insulin-like Growth Factors (33 papers). Robert C. Smallridge collaborates with scholars based in United States, Russia and Canada. Robert C. Smallridge's co-authors include John A. Copland, Henry G. Fein, Laura A. Marlow, Kenneth D. Burman, Juliann G. Kiang, Edward W. Bernton, Keith C. Bible, Judith E. Beach, John W. Holaday and R J Galloway and has published in prestigious journals such as Science, JAMA and Journal of Clinical Oncology.

In The Last Decade

Robert C. Smallridge

206 papers receiving 8.8k citations

Hit Papers

American Thyroid Associat... 1987 2026 2000 2013 2012 1987 2021 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert C. Smallridge 5.3k 2.5k 2.0k 1.3k 1.2k 209 9.1k
Alfredo Pontecorvi 5.7k 1.1× 2.6k 1.0× 1.5k 0.7× 2.9k 2.3× 1.2k 1.0× 437 10.7k
Armen H. Tashjian 3.6k 0.7× 4.8k 1.9× 2.4k 1.2× 1.2k 0.9× 1.5k 1.2× 204 11.4k
Jeff M.P. Holly 3.5k 0.7× 2.9k 1.1× 1.4k 0.7× 521 0.4× 961 0.8× 202 7.3k
Salvatore Benvenga 5.6k 1.0× 1.5k 0.6× 728 0.4× 1.6k 1.3× 1.2k 1.0× 333 9.6k
Sébastiano Filetti 10.0k 1.9× 4.0k 1.6× 1.8k 0.9× 3.5k 2.8× 1.7k 1.4× 268 13.6k
Jae Hoon Chung 5.0k 0.9× 1.6k 0.6× 1.0k 0.5× 2.2k 1.7× 1.0k 0.9× 305 7.4k
Liam J. Murphy 3.9k 0.7× 3.4k 1.3× 873 0.4× 819 0.7× 1.8k 1.5× 159 8.4k
Mario Serio 1.4k 0.3× 2.8k 1.1× 2.1k 1.1× 1.2k 0.9× 851 0.7× 151 8.2k
Antonino Belfiore 6.7k 1.3× 6.6k 2.6× 2.7k 1.3× 2.4k 1.9× 1.5k 1.3× 212 13.1k
Paul G. Walfish 3.2k 0.6× 1.1k 0.4× 811 0.4× 1.6k 1.2× 1.4k 1.1× 160 6.2k

Countries citing papers authored by Robert C. Smallridge

Since Specialization
Citations

This map shows the geographic impact of Robert C. Smallridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Smallridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Smallridge more than expected).

Fields of papers citing papers by Robert C. Smallridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Smallridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Smallridge. The network helps show where Robert C. Smallridge may publish in the future.

Co-authorship network of co-authors of Robert C. Smallridge

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Smallridge. A scholar is included among the top collaborators of Robert C. Smallridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Smallridge. Robert C. Smallridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rivera, Michael, Asha Nair, Yi Liu, et al.. (2024). BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression. Frontiers in Endocrinology. 15. 1440722–1440722.
2.
Bible, Keith C., Electron Kebebew, James D. Brierley, et al.. (2021). 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid. 31(3). 337–386. 374 indexed citations breakdown →
3.
Brito, Juan P., Joseph S. Ross, Yihong Deng, et al.. (2021). Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use. Endocrine. 74(3). 592–602. 1 indexed citations
4.
Sawka, Anna M., Erik K. Alexander, Antônio C. Bianco, et al.. (2020). Challenges in Developing Recommendations Based on Low-Quality Evidence in Thyroid Guidelines. Thyroid. 31(1). 3–7. 2 indexed citations
5.
Landa, Iñigo, Nikita Pozdeyev, Christopher Korch, et al.. (2019). Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies. Clinical Cancer Research. 25(10). 3141–3151. 130 indexed citations
6.
Boufraqech, Myriem, Naris Nilubol, Lisa Zhang, et al.. (2014). miR30a Inhibits LOX Expression and Anaplastic Thyroid Cancer Progression. Cancer Research. 75(2). 367–377. 65 indexed citations
7.
Smallridge, Robert C., Nancy N. Diehl, & Victor Bernet. (2014). Practice Trends in Patients with Persistent Detectable Thyroglobulin and Negative Diagnostic Radioiodine Whole Body Scans: A Survey of American Thyroid Association Members. Thyroid. 24(10). 1501–1507. 18 indexed citations
8.
Smallridge, Robert C., John A. Copland, Marcia S. Brose, et al.. (2013). Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial. The Journal of Clinical Endocrinology & Metabolism. 98(6). 2392–2400. 93 indexed citations
9.
Foote, Robert L., Julian R. Molina, Jan L. Kasperbauer, et al.. (2010). Enhanced Survival in Locoregionally Confined Anaplastic Thyroid Carcinoma: A Single-Institution Experience Using Aggressive Multimodal Therapy. Thyroid. 21(1). 25–30. 110 indexed citations
10.
Marlow, Laura A., Lisa A. Reynolds, Simon Cooper, et al.. (2009). Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth. Cancer Research. 69(4). 1536–1544. 60 indexed citations
11.
Schweppe, Rebecca E., Joshua Klopper, Christopher Korch, et al.. (2008). Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification. The Journal of Clinical Endocrinology & Metabolism. 93(11). 4331–4341. 490 indexed citations
12.
Colón‐Otero, Gerardo, et al.. (2007). Disparities in participation in cancer clinical trials in the United States. Cancer. 112(3). 447–454. 63 indexed citations
13.
Smallridge, Robert C. & Paul W. Ladenson. (2001). Hypothyroidism in Pregnancy: Consequences to Neonatal Health. The Journal of Clinical Endocrinology & Metabolism. 86(6). 2349–2353. 86 indexed citations
14.
Smallridge, Robert C.. (2001). Hypothyroidism in Pregnancy: Consequences to Neonatal Health. The Journal of Clinical Endocrinology & Metabolism. 86(6). 2349–2353. 29 indexed citations
16.
Aloj, Salvatore M., Domenico Liguoro, Juliann G. Kiang, & Robert C. Smallridge. (1993). Purinergic (P2) Receptor-Operated Calcium Entry into Rat Thyroid Cells. Biochemical and Biophysical Research Communications. 195(1). 1–7. 13 indexed citations
17.
Fein, Henry G., Kenneth D. Burman, Stephen J. Usala, et al.. (1991). Tight linkage of the human c-erbAβ gene with the syndrome of generalized thyroid hormone resistance is present in multiple kindreds. Journal of Endocrinological Investigation. 14(3). 219–223. 9 indexed citations
18.
Wartofsky, Leonard, et al.. (1982). Thyrotropin secretion in starved rats is enhanced by somatostatin antiserum. Annales d Endocrinologie. 43(3). 2 indexed citations
19.
Smallridge, Robert C., et al.. (1978). Neonatal thyrotoxicosis: Alterations in serum concentration of LATS-protector, T4, T3, reverse T3, and 3, 3′T2. The Journal of Pediatrics. 93(1). 118–120. 6 indexed citations
20.
Burman, Kenneth D., et al.. (1978). A Radioimmunoassay for 3',5'-Diiodothyronine*. The Journal of Clinical Endocrinology & Metabolism. 47(5). 1059–1064. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026